Targeting the Folate Receptor (FR): Imaging and Cytotoxicity of ReI Conjugates in FR-Overexpressing Cancer Cells
✍ Scribed by Nerissa Viola-Villegas; Amy E. Rabideau; Justin Cesnavicious; Jon Zubieta; Robert P. Doyle
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 360 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1860-7179
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The synthesis, characterization, in vitro imaging, and cytotoxic properties of a new folate conjugate of rhenium(I) are reported. The conjugate [FA‐PEG‐BQAV‐Re(CO)~3~]^+^ (γ‐4) was screened against an adriamycin‐ and cisplatin‐resistant human ovarian cancer cell line (A2780/AD) that overexpresses the folate receptor (FR). Compound γ‐4 was internalized by a folate‐receptor‐mediated endocytotic pathway, which results in internal accumulation of γ‐4. This was contrasted with a FR‐negative Chinese hamster ovary cell line in which no internalization of γ‐4 was observed. γ‐4 was found to be cytotoxic with IC~50~ values of 189 and 78 μM at 6 and 24 h, respectively, toward the FR‐positive cell line. This is in contrast to the IC~50~ value of 502 μM at 6 h and 84 μM at 24 h for cisplatin in the same cell line, with a significantly greater toxicity at the earlier time point. The cytotoxicity of γ‐4 as explained by interactions that occur between the rhenium(I) complex moiety and DNA is described.
📜 SIMILAR VOLUMES
Human epidermal growth factor receptor 2 (HER2) is frequently overexpressed in human breast cancers. It is known to drive tumor growth and progression and represents a prominent target in breast cancer therapy. The endothelin (ET) system, in particular ET-1 and its receptor ET A R, is of major relev